Follow The Filings

TEVA position history

The shares of Teva Pharmaceutical Industries (TEVA) that ARK Investment Management LLC reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 403,996 shares, $3.9M, <0.01% of portfolio
  2. 2021 Q4: 304,792 shares, $2.4M, <0.01% of portfolio, Reduce −24.6%
  3. 2022 Q1: 300,012 shares, $2.8M, 0.01% of portfolio, Reduce −1.6%
  4. 2022 Q2: 232,518 shares, $2.1M, 0.01% of portfolio, Reduce −22.5%
  5. 2022 Q3: 335,468 shares, $2.7M, 0.02% of portfolio, Add +44.3%
  6. 2022 Q4: 259,163 shares, $2.4M, 0.02% of portfolio, Reduce −22.7%
  7. 2023 Q1: 211,778 shares, $1.9M, 0.01% of portfolio, Reduce −18.3%
  8. 2023 Q2: 237,923 shares, $1.8M, 0.01% of portfolio, Add +12.3%
  9. 2023 Q3: 254,810 shares, $2.6M, 0.02% of portfolio, Add +7.1%
  10. 2023 Q4: 222,806 shares, $2.3M, 0.01% of portfolio, Reduce −12.6%
  11. 2024 Q1: 192,136 shares, $2.7M, 0.02% of portfolio, Reduce −13.8%
  12. 2024 Q2: 169,420 shares, $2.8M, 0.02% of portfolio, Reduce −11.8%
  13. 2024 Q3: 123,865 shares, $2.2M, 0.02% of portfolio, Reduce −26.9%
  14. 2024 Q4: 100,443 shares, $2.2M, 0.02% of portfolio, Reduce −18.9%
  15. 2025 Q1: 90,253 shares, $1.4M, 0.01% of portfolio, Reduce −10.1%
  16. 2025 Q2: 120,874 shares, $2M, 0.01% of portfolio, Add +33.9%
  17. 2025 Q3: 118,721 shares, $2.4M, 0.01% of portfolio, Reduce −1.8%
  18. 2025 Q4: 105,131 shares, $3.3M, 0.02% of portfolio, Reduce −11.4%
  19. 2026 Q1: 68,279 shares, $2.1M, 0.02% of portfolio, Reduce −35.1%
  20. 2026 Q2: 68,653 shares, $2.3M, 0.02% of portfolio, Add +0.5%
  21. 2026 Q3: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders